Beyond the Placebo: Understanding How Clinical Trials Measure What Works
The Final Chapter in Our CISCRP Educational Series
When researchers study a new treatment, one of the biggest challenges is determining whether the treatment itself is responsible for the changes participants experience.
A person might report feeling better after receiving a treatment. Another might notice unexpected symptoms. But how can researchers tell whether those changes are connected to the treatment, a person's expectations, or something else entirely?
This is where placebos can play an important role in clinical research.
In our previous discussion about placebos and clinical trial myths, we explored common concerns about receiving a placebo and what participants should know before enrolling.
For the final installment of our educational series featuring resources from the Center for Information and Study on Clinical Research Participation (CISCRP), we're taking that conversation a little further. This time, we're looking at how placebos help researchers interpret results and what that process means for the people participating.
The Difference Between Experiencing a Change and Proving a Treatment Works
Imagine two groups of people participating in a clinical trial. One group receives the investigational treatment, while the other receives a placebo, something that looks like the treatment but does not contain its active ingredient.
Throughout the study, researchers observe what happens in both groups.
If participants in both groups report similar improvements, researchers must consider whether factors other than the investigational treatment contributed to those results.
If meaningful differences emerge between the groups, those findings may help researchers better understand the treatment's effects.
The purpose isn't simply to see whether someone feels better. It's to gather reliable evidence about what may be causing those changes.
When Expectations Influence the Experience
One particularly interesting part of placebo research is the relationship between expectations and how people experience symptoms.
CISCRP explains that the placebo effect can involve both positive and negative experiences.
For example, someone who believes a treatment will help might report feeling better, even when the treatment contains no active medication. Similarly, someone who expects side effects might experience symptoms they associate with the treatment.
These experiences matter because researchers need to understand the difference between a treatment's effects and changes that may be influenced by expectations.
By studying both groups, researchers can better interpret the information they collect rather than relying on assumptions.
Why Some Participants Don't Know Which Treatment They're Receiving
Another important part of the process involves how participants are assigned to treatment groups.
In many placebo-controlled clinical trials, researchers use a process called randomization. A computer program randomly assigns participants to different groups, helping reduce potential bias in the study.
Some trials also use blinding, meaning participants are not told whether they're receiving the investigational treatment or a placebo.
In certain studies, the research team may not know which treatment a participant is receiving either.
These methods help researchers evaluate results without expectations influencing how outcomes are reported or assessed.
Although participants may not know their assigned group during a blinded trial, they are informed before enrolling that receiving a placebo is a possibility.
What Happens If Your Health Changes During the Trial?
Understanding how a trial collects information is important, but so is knowing what happens if your medical needs change.
According to CISCRP's educational brochure, participants are monitored throughout clinical trials, regardless of whether they receive a placebo or an investigational treatment.
If a participant's medical condition changes, the research team discusses the situation with them. Depending on the circumstances, the team may recommend a different treatment or withdrawal from the study.
For individuals who require standard medical treatment, the study plan must also address their ongoing medical needs.
Every clinical trial plan is reviewed by an Institutional Review Board (IRB), which evaluates the research and its protections for participants.
These considerations are part of why understanding a study's design matters before agreeing to participate.
Will You Ever Find Out If You Received a Placebo?
This is a question participants may not think to ask until a study is already underway.
In blinded studies, treatment assignments are generally kept confidential while the research is taking place. However, there may be circumstances, such as a medical emergency, when knowing the assigned treatment becomes necessary.
At the conclusion of a trial, participants may be told whether they received the placebo or investigational treatment.
Because procedures vary between studies, it's important to ask the research team how and when treatment assignments may be disclosed.
Bringing Our Educational Series Full Circle
Throughout this CISCRP educational series, we've explored different parts of the clinical research experience, from understanding participant rights and navigating informed consent to learning about study-related costs and the decisions involved in participation.
Each topic has highlighted a different part of the same process: helping individuals better understand what clinical research involves.
The discussion around placebos brings several of those lessons together.
Clinical trials require careful scientific methods to produce meaningful results. At the same time, participants deserve clear explanations of how those methods may affect their experience.
Understanding both sides helps make research more transparent and gives individuals the information they need to make decisions about participation.
Continuing the Conversation
At Kalo Clinical Research, we believe education should be an ongoing part of the relationship between research teams and the communities they serve.
As we conclude this CISCRP educational brochure series, we encourage you to continue exploring the questions that matter most to you.
Whether you're learning about clinical research for the first time or considering participation in a study, reliable information can help guide meaningful conversations with your healthcare providers and research professionals.
Explore more educational resources: Visit the CISCRP Education Center to learn more about clinical research participation, or explore Kalo Clinical Research to learn about our work and current research opportunities.
Educational Resource: This article was developed using information from CISCRP's "What Is a Placebo? And Why Are Placebos Used in Clinical Trials?" brochure. CISCRP is an independent nonprofit organization dedicated to educating and engaging the public and patients as partners in clinical research.
